Elie Dolgin, PHD, Science Journalist
Nature Outlook logo

Nature Outlook

People being evacuated following flooding caused by the destruction of the Kakhovka dam in Ukraine.
By Elie Dolgin 14 Dec, 2023
Climate change could intensify the role of this vital and strategic asset in armed conflict.
Oliver DeLong and his mother, Hillary DeLong
By Elie Dolgin 27 Sep, 2023
Drugs that counter RSV infection can safeguard newborns, offering another mode of protection alongside vaccines.
Nicholas Vitanza (left) treated Emily Hood (right) using CAR-T-cell therapy
By Elie Dolgin 19 Dec, 2022
The immunotherapy is beginning to show promise in solid tumours, but researchers want more dedicated research in young people.
Scanning electron micrograph of human brain cells — can psychedelics rewire them safely?
By Elie Dolgin 28 Sep, 2022
Drugs under development offer the mental-health benefits of psilocybin and similar substances without inducing strong hallucinatory effects.
Illustration of pill bottle being squeezed.
By Elie Dolgin 30 Mar, 2022
Finite courses of treatment could get the virus under control — with the right combination of drugs.
Illustration of cell garbage disposal
By Elie Dolgin 19 Jan, 2022
Could targeting autophagy — often likened to a cellular trash management system — extend life? Some researchers are unconvinced.
Tea cups in a line
By Elie Dolgin 06 Feb, 2019
Genetic manipulation and innovative breeding techniques are paving the way to new tea varieties.
Lab-grown meat with cheese stacked 2 layers high
By Elie Dolgin 06 Feb, 2019
'Clean meat’ firms have drawn tens of millions of dollars in investment in recent years, but technical hurdles remain.
Peter Younis, a cattle veterinarian, with one of his patients, a Holstein cow
By Elie Dolgin 14 Nov, 2018
The dramatic success of ibrutinib has created a more hopeful reality for people with lymphoma, as targeted therapies fill the pipeline.
Elli Hofmeister in a store with a cup, smiling for the camera
By Elie Dolgin 30 May, 2018
Although it usually affects people in middle age, the inherited neurodegenerative condition can also develop in children and teenagers.
Show More
Share by: